Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That you at the close of play then. Even though this share isn't moving I cant help but check frequently any activity. Someone has patiently been building over the last few weeks, Plant Health (PHC) has had some large buys over the last few days, not a holder of PHC but like to see whats going on
http://www.vccircle.com/500/news/crystal-crop-protection-raises-rs-150cr-from-everstone-capital Nov 9, 2011 Private equity firm Everstone Capital has invested Rs 150 crore in Crystal Crop Protection Pvt Ltd, a Delhi-based manufacturer of crop protection chemicals, the firm announced on Wednesday. VCCircle was the first to report the deal on November 3rd. Headquartered in Delhi, Crystal Crop Production is engaged in the business of pesticide formulations, products like fungicides, insecticides, herbicides, seeds besides agri-equipment such as spray pumps among other categories. Founded by first generation entrepreneur NK Aggarwal in 1983, the agro- chemical company is now run actively by his son Ankur Aggarwal who spearheads the operations. Always good to see the PE firms on the lookout for bolt ons, they are always ahead of the game (well the good ones anyway) The firm has manufacturing facilities in Jammu and Haryana and employs 600 people. The capital raised will be primarily used to help Crystal further consolidate its position in the Indian market, strengthen its presence in the international markets, enhance its existing product portfolio, and explore inorganic growth opportunities in India and abroad, the firm said on Wednesday. “India has the largest area under cultivation for many crops but productivity is significantly lower than world averages – with increased industrialisation and urbanisation, productivity improvements are a necessity to meet India’s food requirements. Crystal is well positioned to take advantage of this requirement and has an attractive business model backed by a respectable management team that can build Crystal into one of India's foremost crop protection and agri-services Company,” said Dhanpal Jhaveri, partner and CEO, Everstone Capital. Everstone Capital that manages over $1.5 billion in capital, across two PE funds, one real estate fund and one industrial warehousing fund, was co-founded by Sameer Sain and Atul Kapur who remain the firm’s managing partners. It recently closed a $580 million PE fund for the Indian market.
Larger then normal volume today with large buys this afternoon with bigger sells this morning and the share price remains the same. Eagerly awaiting the interims soon, im assuming that the turnover has increased due to the increase in distribution network, would expect update from PIM before the year end
Anyone know when the interims are due? 6 months ended Sep11.
http://www.farmchemicalsinternational.com/news/cropprotection/?storyid=3275 Arysta LifeScience has launched a unique portfolio of plant nutrient products in Thailand, according to a recent company statement. The launch follows two years of research and field trials with growers of rice and horticultural crops in Thailand. The new portfolio includes four products from the Arysta LifeScience acquisition of Grupo Bioquímico Mexicano (GBM) in 2007,including: • BIOZYME, a complex of phytohormone, used to help flowering, fruit setting and fighting abiotic stess during the critical period in tomatoes and strawberries; • FOLTRON PLUS, a balance of humic acid, folcystein and various foliar fertilizers, to help boost yields in rice, tomato and cucumber; and • PILATUS and K-TIONIC, which help plants, such as rice, develop strong root systems. A fifth product, INCA, rounds out the company’s plant nutrient portfolio. INCA is a proprietary product that was first developed by Plant Impact and will be marketed in Thailand by Arysta LifeScience under an exclusive distribution and marketing agreement. INCA is a calcium delivery system that moves calcium at a cellular level, giving greater calcium penetration to plants where needed. It reduces the risk of calcium disorders by helping to control stress and by building healthier cells, according to the company. INCA has been shown to increase yields, enhance crop quality and improve shelf life, especially for root crops such as potatoes and Chinese radish, according to Arysta. With the addition of these new, innovative products to its existing crop protection portfolio, Arysta LifeScience hopes to be one of the main players in the plant nutrient segment in Thailand within five years, according to the company. Editor's note: The marketing agreement between Plant Impact and Arysta LifeScience was addressed due to an error in the original press release. I hope that Arysta have noticed the comment below this article. Do you think it is worth highlighting for them?
Did anyone go to the meeting with Chairman & CEO yesterday?
How come yoy topped up? Do you know something we dont or do you believe that PIM is going to be a big'un?
http://www.hardmanandco.com/Research/Plant%20Technology%20Oct11.pdf Thanks to N&S from iii for posting, dont have a iii account so thanks if you see this
you sound like the takeover is almost a sure thing. I agree that there is a lot of evidence of a potential takeover, from RNS 9/8/11: “Brubaker served as the global head of business development for Tokyo-based Arysta LifeScience Corporation ("Arysta"), a 9.1% shareholder in Plant Impact and a key commercial partner for the future . Having worked at Arysta since 2005, he was responsible for all aspects of global acquisitions, divestures and various other strategic initiatives”. Seems like the ideal guy to slot PIM into Arysta but do agree that US approval is needed first. Thought we would have had some sort of update during September but hopefully this means that they are working hard burning the red tape.
The Arysta deal should have provided cash for forseeable future?
Possible cash call here. Delay in registration and sudden, unexpected departure of both Chairman and CEO suggests it's possible. Any thoughts? I am a long term holder.
crop enhancement did not do it for me. Like this part though The subscription price of 45 pence by Arysta Lifescience and the 76.47 per cent. premium to the closing mid market price of 25.5 the cooperation thing is interesting. Not sure if it is going to set the world on fire probably necessary work somewher down the line. You got to have a herd to buy to lift the price and volume. Got a few sellers in here...I prefer TEG this got a place somewhere. Will keep an eye on it..see where it goes..
This does not look like the acta board or for that matter teg...Lets take a look...
continues. a deal for 23p and 26p and two lots of 100k deals. would anyone like to translate?
Yes - the 2 on Friday, particularly the director deal make me think there is further news to follow.
Shorter the mm's are in a stock the more they manipulate it, defies logic people selling below the purchase price of such a large director buy but the mm will take plenty more at 22.6p online if others want to bail but i think when they let this go it will be quickly back in the 25-30p range again.
have I got this right - David Jones bought 250,000 shares,so his present holding is .....250,000 shares mmmm ..what a lot of confidence he had that his company would make good.!!
Rang up the mm would not budge past 23p for 2000, what a joke,still i managed some the other week at 18.8p which makes up for the ones i bought at 27p.
MM chit chat? anyone have any ideas what the 26p trade means
this buyer was spotted last week. the inability to buy stock and the ability to sell was telling. it would be nice if our chairman would make a substantial purchase however, i suspect this is an II that was building a position a few months ago....
250k trades are both big and rare for this stock, i really think there's a stakebuilder about and a broker must have rang around to get that stock, to a seller full offer is a very fair price so i make that a 250k cross trade, mm's dont hold that kind of stock to let go in one transaction
All sales yet can sell 50k online 20.65p, cannot get a quote to buy 5k which is very unusual, any buying and this will go as the mm's are either short or have a decent buy order.
It sounds like good new, Arysta want a return from their 45p investment so plans are being made, think they need to go to the market as well and buy more stock.